Co-Diagnostics (CODX) Misses Q2 EPS by 7c

Co-Diagnostics (NASDAQ: CODX) reported Q2 EPS of ($0.31), $0.07 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $500 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• UBS Reiterates Buy Rating on Dollar Tree (DLTR)
• Raymond James Previews Charles Schwab Corp. (SCHW) Earnings: 'Elevated Trading Volumes Drives Trading Revenue Upside'